Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections
- 1.1k Downloads
An acid-buffering bioadhesive vaginal tablet was developed for the treatment of genitourinary tract infections. From the bioadhesion experiment and release studies it was found that polycarbophil and sodium carboxymethylcellulose is a good combination for an acid-buffering bioadhesive vaginal tablet. Sodium monocitrate was used as a buffering agent to provide acidic pH (4.4), which is an attribute of a healthy vagina. The effervescent mixture (citric acid and sodium bicarbonate) along with a superdisintegrant (Ac-Di-sol) was used to enhance the swellability of the bioadhesive tablet. The drugs clotrimazole (antifungal) and metronidazole (antiprotozoal as well as an antibacterial) were used in the formulation along withLactobacillus acidophilus spores to treat mixed vaginal infections. From the ex vivo retention study it was found that the bioadhesive polymers hold the tablet for more than 24 hours inside the vaginal tube. The hardness of the acid-buffering bioadhesive vaginal tablet was optimized, at 4 to 5 kg hardness the swelling was found to be good and the cumulative release profile of the developed tablet was matched with a marketed conventional tablet (Infa-V). The in vitro spreadability of the swelled tablet was comparable to the marketed gel. In the in vitro antimicrobial study it was found that the acid-buffering bioadhesive tablet produces better antimicrobial action than marketed intravaginal drug delivery systems (Infa-V, Candid-V and Canesten 1).
KeywordsBioadhesion Bioadhesive polymers Vaginal infections Acid-buffering bioadhesive tablet Mixed vaginal infections
- 4.Yu K, Chien YW. Vaginal delivery and absorption of drugs. In: Swarbrick J, Boylan JC, eds.Encyclopedia of Pharmaceutical Technology. vol. 16. New York, NY: Marcel Dekker Inc.; 1997:153–185.Google Scholar
- 8.Levinson RS, Thompson DJ. VagiSite bioadhesive technology. In: Rathbone MJ, Hadgraft J, Roberts MS, eds.Modified-release Drug Delivery Technology. New York, NY: Marcel Dekker; 2003:801–806.Google Scholar
- 11.Singh S, Garg S. Understanding analytical method validation.Pharm Times. 1999;8:15–20.Google Scholar